FRANKFURT--The following is a summary of analysts' forecasts for
Sanofi SA (SNY) second-quarter results, based on a poll of seven
analysts conducted by Dow Jones Newswires (figures in million
euros, EPS, dividend and target price in euro, according to IFRS).
Earnings figures are scheduled to be released July 31.
===
Net Business Business Business
2nd Quarter sales Oper. Income net income EPS
AVERAGE 8,047 2,067 1,473 1.12
Prev. Year 8,003 2,017 1,475 1.11
+/- in % +0.5 +2.5 -0.2 +1.3
MEDIAN 8,025 2,062 1,470 1.12
Maximum 8,178 2,214 1,567 1.18
Minimum 7,967 1,845 1,335 1.02
Amount 7 7 7 7
Bernstein 8,120 2,062 1,470 1.12
Cowen and Company 7,970 1,845 1,335 1.02
Deutsche Bank 7,991 2,160 1,513 1.18
Exane BNP Paribas 7,967 2,022 1,455 1.11
Helvea 8,178 2,214 1,567 1.18
J.P. Morgan 8,076 2,130 1,505 1.15
Morgan Stanley 8,025 2,037 1,463 1.11
Target price Rating DPS 2014
AVERAGE 84.40 positive 3 AVERAGE 2.91
Prev. Quarter 85.25 neutral 2 Prev. Year 2.80
+/- in % -1.0 negative 0 +/- in % +3.8
MEDIAN 82.00 MEDIAN 2.94
Maximum 90.00 Maximum 2.95
Minimum 81.00 Minimum 2.83
Amount 5 Amount 3
Cowen and Company -- Market perform --
Deutsche Bank 87.00 Buy 2.95
Exane BNP Paribas 82.00 -- 2.94
Helvea 82.00 Buy --
J.P. Morgan 81.00 Neutral --
Morgan Stanley 90.00 Overweight 2.83
===
Year-earlier figures are as reported by the company.
DJG/voi
Subscribe to WSJ: http://online.wsj.com?mod=djnwires